Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael A. Fifer, M.D.

Co-Author

This page shows the publications co-authored by Michael Fifer and Aaron Baggish.
Connection Strength

1.153
  1. Pathological effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Heart. 2006 Dec; 92(12):1773-8.
    View in: PubMed
    Score: 0.355
  2. Catecholamine response to exercise in patients with non-obstructive hypertrophic cardiomyopathy. J Physiol. 2019 03; 597(5):1337-1346.
    View in: PubMed
    Score: 0.212
  3. Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy. JACC Heart Fail. 2013 Dec; 1(6):480-7.
    View in: PubMed
    Score: 0.148
  4. Management strategy in 249 consecutive patients with obstructive hypertrophic cardiomyopathy referred to a dedicated program. Am J Cardiol. 2012 Oct 15; 110(8):1169-74.
    View in: PubMed
    Score: 0.135
  5. Anabolic androgenic steroid induced myocardial toxicity: an evolving problem in an ageing population. BMJ Case Rep. 2011 Aug 17; 2011.
    View in: PubMed
    Score: 0.127
  6. Still a kid at heart: hypertrophic cardiomyopathy in the elderly. Circulation. 2011 Aug 16; 124(7):857-63.
    View in: PubMed
    Score: 0.127
  7. Clinical Correlates and Prognostic Value of Elevated Right Atrial Pressure in Patients With Hypertrophic Cardiomyopathy. Circ J. 2018 04 25; 82(5):1405-1411.
    View in: PubMed
    Score: 0.050
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.